These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10720807)

  • 1. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii.
    Tavío MM; Vila J; Ruiz J; Martín Sánchez AM; Jiménez de Anta MT
    Int J Antimicrob Agents; 2000 Mar; 14(2):157-60. PubMed ID: 10720807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First characterisation of plasmid-mediated quinolone resistance-qnrS1 co-expressed bla CTX-M-15 and bla DHA-1 genes in clinical strain of Morganella morganii recovered from a Tunisian Intensive Care Unit.
    Mahrouki S; Bourouis A; Chihi H; Ouertani R; Ferjani M; Moussa MB; Barguellil F; Belhadj O
    Indian J Med Microbiol; 2012; 30(4):437-41. PubMed ID: 23183469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate decreases production of AmpC type beta-lactamases and increases susceptibility to beta-lactams in a Morganella morganii clinical isolate.
    Tavío MM; Perilli M; Vila J; Becerro P; Casañas L; Amicosante G; Jiménez de Anta MT
    FEMS Microbiol Lett; 2004 Sep; 238(1):139-44. PubMed ID: 15336414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii.
    Ruzin A; Keeney D; Bradford PA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):791-3. PubMed ID: 15673770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition.
    Tavío M; Vila J; Ruiz J; Amicosante G; Franceschini N; Martín-Sánchez AM; de Anta MT
    J Antimicrob Chemother; 2000 Apr; 45(4):521-4. PubMed ID: 10747831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integron presence in a multiresistant Morganella morganii isolate.
    Rojas L; Vinuesa T; Tubau F; Truchero C; Benz R; Viñas M
    Int J Antimicrob Agents; 2006 Jun; 27(6):505-12. PubMed ID: 16690260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
    Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N; Inoue M; Inoue K; Yamaguchi T; Mitsuhashi S
    Chemotherapy; 1990; 36(5):345-55. PubMed ID: 2209168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Draft genome sequencing and annotation of a low-virulence Morganella morganii strain CQ-M7, a multidrug-resistant isolate from the giant salamander in China.
    Zhao G; Luo Z; Wang Y; Liu J; Wu D; Zhang L; Yang X
    J Glob Antimicrob Resist; 2020 Mar; 20():248-252. PubMed ID: 31449965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of quinolone resistance determinant qnrA6 among broad- and extended-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates with sul1-type class 1 integron association in a Tunisian Hospital.
    Mahrouki S; Perilli M; Bourouis A; Chihi H; Ferjani M; Ben Moussa M; Amicosante G; Belhadj O
    Scand J Infect Dis; 2013 Aug; 45(8):600-5. PubMed ID: 23746343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
    Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
    J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
    Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro.
    Lecso-Bornet M; Pierre J; Sarkis-Karam D; Lubera S; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1992 Mar; 36(3):669-71. PubMed ID: 1622183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.
    Fukuda H; Hosaka M; Iyobe S; Gotoh N; Nishino T; Hirai K
    Antimicrob Agents Chemother; 1995 Mar; 39(3):790-2. PubMed ID: 7793896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular investigation of extended-spectrum beta-lactamase genes and potential drug resistance in clinical isolates of Morganella morganii.
    Al-Muhanna AS; Al-Muhanna S; Alzuhairi MA
    Ann Saudi Med; 2016; 36(3):223-8. PubMed ID: 27236395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
    Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
    Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morganella morganii, a non-negligent opportunistic pathogen.
    Liu H; Zhu J; Hu Q; Rao X
    Int J Infect Dis; 2016 Sep; 50():10-7. PubMed ID: 27421818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of KPC-2 and qnrS1 in clinical isolates of Morganella morganii from China.
    Cai JC; Yang W; Hu YY; Zhang R; Zhou HW; Chen GX
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):207-9. PubMed ID: 22542894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.
    Liu J; Takiff HE; Nikaido H
    J Bacteriol; 1996 Jul; 178(13):3791-5. PubMed ID: 8682782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.